RSPH1 Gene Primary Ciliary Dyskinesia Type 24 Genetic Test sale cost 4400 AED
COL4A6 Gene Deafness X-Linked Type 6 Genetic Test sale cost 4400 AED COL4A6 Gene Deafness X-Linked Type 6 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
DNAH9 Gene Primary Ciliary Dyskinesia DNAH9 Related Genetic Test sale cost 4400 AED DNAH9 Gene Primary Ciliary Dyskinesia DNAH9 Related Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

RSPH1 Gene Primary Ciliary Dyskinesia Type 24 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RSPH1 Gene Primary Ciliary Dyskinesia Type 24 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, aimed at detecting mutations in the RSPH1 gene, which are implicated in Primary Ciliary Dyskinesia (PCD) type 24. PCD is a rare genetic disorder characterized by chronic respiratory tract infections, abnormal organ positioning, and fertility issues, resulting from defects in the structure and function of cilia. The RSPH1 gene plays a crucial role in the development and operation of these cilia. Identifying mutations in this gene can confirm a diagnosis of PCD type 24, enabling targeted management and treatment strategies for affected individuals. The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the RSPH1 gene. This test is crucial for families with a history of PCD, as it can aid in early diagnosis and intervention, potentially improving the quality of life for those affected by the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RSPH1 Gene Primary ciliary dyskinesia type 24 Genetic Test

At DNA Labs UAE, we offer the RSPH1 Gene Primary ciliary dyskinesia type 24 Genetic Test at a cost of AED 4400.0. This test is used to diagnose primary ciliary dyskinesia type 24 (PCD24), a rare genetic disorder characterized by abnormal cilia structure and function.

Test Components

The RSPH1 Gene Primary ciliary dyskinesia type 24 Genetic Test includes:

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the RSPH1 Gene Primary ciliary dyskinesia type 24 Genetic Test, it is important to provide the clinical history of the patient who is going for the PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN39.

Test Details

The RSPH1 gene is associated with primary ciliary dyskinesia type 24 (PCD24), a rare genetic disorder characterized by abnormal cilia structure and function. Cilia are hair-like structures found on the surface of cells that play a crucial role in moving fluids and particles in various organs, including the respiratory tract, reproductive system, and the lining of the brain.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be causing a specific disorder or condition. In the case of PCD24, NGS genetic testing can detect mutations in the RSPH1 gene that are associated with primary ciliary dyskinesia. By identifying these genetic mutations, healthcare providers can make an accurate diagnosis of PCD24 and provide appropriate treatment and management options for affected individuals.

Genetic testing can also help in identifying carriers of the condition, which can be important for family planning and genetic counseling purposes.

Test Name RSPH1 Gene Primary ciliary dyskinesia type 24 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN39
Test Details

The RSPH1 gene is associated with primary ciliary dyskinesia type 24 (PCD24), a rare genetic disorder characterized by abnormal cilia structure and function. Cilia are hair-like structures found on the surface of cells that play a crucial role in moving fluids and particles in various organs, including the respiratory tract, reproductive system, and the lining of the brain.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be causing a specific disorder or condition. In the case of PCD24, NGS genetic testing can detect mutations in the RSPH1 gene that are associated with primary ciliary dyskinesia.

By identifying these genetic mutations, healthcare providers can make an accurate diagnosis of PCD24 and provide appropriate treatment and management options for affected individuals. Genetic testing can also help in identifying carriers of the condition, which can be important for family planning and genetic counseling purposes.

SKU: TEST-2780 Category:

Related products